查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
免疫分析市場 - 策略和趨勢：依應用、技術、產品、使用者和國家/地區進行預測 - 附加執行顧問指南（2024-2028）
市場調查報告書
商品編碼
1472614

免疫分析市場 - 策略和趨勢：依應用、技術、產品、使用者和國家/地區進行預測 - 附加執行顧問指南（2024-2028）

IMMUNOASSAY MARKETS. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive and Consultant Guides. 2024 to 2028
出版日期: | 出版商: Howe Sound Research | 英文 409 Pages | 商品交期: 最快1-2個工作天內

價格

診斷產業的旗艦產品再次成為關注的焦點。這場大流行對快速、便捷的診斷產生了新的需求。免疫測定在其中發揮了作用。遺傳知識的進步正在為免疫分析創造新的市場。多廳影院正成為籌碼。雖然快速診斷、現場護理、生物標記和消費者市場正在擴大，但傳統的免疫測定方法在不斷增長的臨床診斷市場中保持著強勢地位。

該報告考察了全球免疫分析市場，並提供了市場概述，包括依應用、技術、產品、用戶、國家和參與市場的公司概況劃分的趨勢。

目錄

第一章 市場引導

第二章介紹和市場定義

  • 免疫分析市場定義
  • 市場定義
  • 調查方法
  • 觀點：醫療保健和IVD產業

第三章 行業概況

  • 市場進入組織
    • 學術研究所
    • 診斷測試開發人員
    • 儀器儀表供應商
    • 藥品及試劑製造商
    • 病理學供應商
    • 獨立臨床實驗室
    • 公共國家/地區實驗室
    • 醫院實驗室
    • 臨床實驗室
    • 審計機構
    • 認證機構
  • 臨床檢測細分市場
  • 免疫分析 - 市場和討論

第四章 市場趨勢

  • 增長動力
  • 生長抑制因素
  • 免疫分析設備

第五章免疫分析方法的最新進展

第六章 主要公司簡介

  • Abbott Laboratories
  • Abcam
  • Abionic
  • Accel Diagnostics
  • Agilent
  • Akonni Biosystems
  • Applied BioCode
  • Arlington Scientific
  • Arrayit Corporation
  • Atomo Diagnostics
  • Aureum Diagnostics
  • Aurora Biomed
  • Autobio Diagnostics
  • AVIVA Systems Biology
  • Awareness Technology
  • Axis-Shield Diagnostics Ltd.
  • Beckman Coulter Diagnostics（Danaher）
  • Becton, Dickinson and Company
  • Biocartis
  • Biomatik
  • bioMerieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Synthesis
  • Bio-Techne
  • Boditech Med, Inc
  • Boster Biological Technology
  • Bruker
  • Cerstest Biotec
  • Chembio
  • CTK Biotech
  • Cue Health
  • Cytena
  • Diasorin S.p.A.
  • Dynex Technologies
  • Eiken Chemical
  • Enzo Biochem
  • Eurofins Scientific
  • Fluxion Biosciences（Cell Microsystems）
  • FUJIFILM Wako Diagnostics
  • Fujirebio
  • Global Access Diagnostics
  • Gold Standard Diagnostics
  • Greiner Bio-One
  • Grifols
  • Hycor Biomedical
  • Immunodiagnostic Systems（IDS）
  • Iollo
  • JR Biomedical
  • LightDeck Diagnostics
  • LumiraDx
  • Maxim Biomedical
  • Meso Scale Discovery
  • Millipore Sigma
  • Mindray
  • Molecular Devices
  • MP Biomedical
  • Operon
  • OraSure Technologies
  • Qiagen
  • QuidelOrtho
  • R&D Systems
  • Randox Toxicology
  • R-Biopharm AG
  • Response Biomedical
  • Revvity
  • Roche Diagnostics
  • SD Biosensor
  • Siemens Healthineers
  • Standard BioTools
  • Sysmex
  • Tecan
  • Thermo Fisher Scientific
  • TOSOH Bioscience
  • Uniogen
  • Veramarx
  • Veredus Laboratories
  • Vircell
  • Wantai Biopharm
  • Werfen
  • YD Diagnostics
  • Zhejiang Orient Gene Biotech

第七章 世界市場

  • 依國家劃分的世界市場
  • 依應用劃分的全球市場
  • 依技術劃分的世界市場
  • 依產品劃分的全球市場
  • 依用戶劃分的全球市場

第八章全球免疫分析市場（依應用）

  • 內分泌學
  • 免疫
  • 腫瘤學
  • 感染
  • 心臟病學
  • 其他

第九章全球免疫分析市場（依技術）

  • 酵素
  • 螢光
  • 化學發光
  • 核酸
  • 快速/POC
  • 其他

第十章全球免疫分析市場，依產品

  • 機器
  • 試劑
  • 服務

第十一章全球免疫分析市場，依使用者劃分

  • 醫院
  • 門診檢查室
  • 概念驗證/其他

第十二章免疫分析的未來願景

第十三章附錄

OVERVIEW:

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up. Advances in genetic knowledge are creating new markets for immunoassay. Multiplex is becoming table stakes. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics. We profile over 80 companies, working in this area. Learn all about the pitfalls and opportunities in this extensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1. Market Guides

  • 1.1. Immunoassay Market-Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. Immunoassay Markets Definition In This Report
    • 2.1.1. Enzyme Based
    • 2.1.2. Immunofluorescence
    • 2.1.3. Chemiluminescence
    • 2.1.4. DNA/NAT
    • 2.1.5. RIA & Other
    • 2.1.6. Reagents/Kits, Analyzers, Software & Services
    • 2.1.7. Infectious Disease
    • 2.1.8. Auto Immune
    • 2.1.9. Endocrinology
    • 2.1.10. Oncology
    • 2.1.11. Cardiology
    • 2.1.12. Other Specialty
  • 2.2. Market Definition
    • 2.2.1. Market Sizes
    • 2.2.2. Currency
    • 2.2.3. Years
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Industry Overview

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. The Clinical Laboratory Market Segments
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
    • 3.2.3. Hospital Testing Share
    • 3.2.4. Economies of Scale
    • 3.2.5. Hospital vs. Central Lab
    • 3.2.6. Physician Office Lab's
    • 3.2.7. Physician's and POCT
  • 3.3. Immunoassay -Markets and Discussion
    • 3.3.1. Instruments-Genetics changes the picture
      • 3.3.1.1. RIA-A Technology Shows its Age
      • 3.3.1.2. Immunoassay vs. PCR vs. Sequencing-A See Saw Battle
      • 3.3.1.3. The Smart Shrinking Instrument-Serious Implications
      • 3.3.1.4. Research Funding and Capital Expense-Instrument Pooling
      • 3.3.1.5. Multiplex vs. POC-A Tradeoff Analysis
    • 3.3.2. Reagents and Kits-Genetics changes the picture
      • 3.3.2.1. Bigger Test Menus a Boon for Kit Market
      • 3.3.2.2. Physician Office Labs-A New Frontier
    • 3.3.3. Rapid and POCT to Threaten Instrument Markets
    • 3.3.4. OTC and DTC-Huge Market Potential
    • 3.3.5. Economies of Scale. Going Away?
    • 3.3.6. Lower Barriers to Entry for Instruments/Analyzers
    • 3.3.7. Miniturization and Technology Drive Acquisition

4. Market Trends

  • 4.1. Factors Driving Growth
    • 4.1.1. Diagnostic Factors
    • 4.1.2. Changing Technologies Spur Early Instrument Retirement
    • 4.1.3. Consumer Channels Open Wider
    • 4.1.4. Immunity Technology Comes of Age
  • 4.2. Factors Limiting Growth
    • 4.2.1. Increased Competition Lowers Price
    • 4.2.2. Threat from PCR Based Instruments
    • 4.2.3. Lower Barriers to Entry
    • 4.2.4. Wellness has a downside
  • 4.3. Immunoassay Instrumentation
    • 4.3.1. Instrumentation Tenacity
    • 4.3.2. Declining Cost of Instruments Changes Industry Structure
    • 4.3.3. Immunoassay-CRISPR Diagnostics

5. Immunoassay Recent Developments

  • 5.1. Recent Developments-Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Single-Molecule Detection Tech Shows Promise
  • 5.3. QuidelOrtho Vitros Fentanyl Test
  • 5.4. Labcorp: Plasma Phosphorylated-Tau 217
  • 5.5. Renalytix Gets Immunoassay Medicare Coverage
  • 5.6. Roche to Acquire LumiraDx POC Tech
  • 5.7. Fujirebio, Sysmex to Collaborate on Immunoassay Development
  • 5.8. EDP Biotech, New Day Diagnostics to Merge
  • 5.9. Sorrento Therapeutics Nabs Contract for Dx Platform
  • 5.10. Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
  • 5.11. Qorvo Eyes Multiplex Immunoassay
  • 5.12. BioMerieux Launches New Products
  • 5.13. Senzo to Commercialize Infectious Disease Lateral Flow Tests
  • 5.14. Nanomix Plans Instrument, Test Launches
  • 5.15. Startup GLX Analytix Prepares for Commercialization
  • 5.16. Nonagen Gets CE Mark for Bladder Cancer Immunoassay
  • 5.17. Qualigen Acquires Majority Stake in NanoSynex
  • 5.18. Saladax Biomedical Using Immunoassay Dx
  • 5.19. Prolight Diagnostics to Acquire Psyros Diagnostics
  • 5.20. Quidel to Acquire Ortho Clinical Diagnostics

6. Profiles of Key Companies

  • 6.1. Abbott Laboratories
  • 6.2. Abcam
  • 6.3. Abionic
  • 6.4. Accel Diagnostics
  • 6.5. Agilent
  • 6.6. Akonni Biosystems
  • 6.7. Applied BioCode
  • 6.8. Arlington Scientific
  • 6.9. Arrayit Corporation
  • 6.10. Atomo Diagnostics
  • 6.11. Aureum Diagnostics
  • 6.12. Aurora Biomed
  • 6.13. Autobio Diagnostics
  • 6.14. AVIVA Systems Biology
  • 6.15. Awareness Technology
  • 6.16. Axis-Shield Diagnostics Ltd.
  • 6.17. Beckman Coulter Diagnostics (Danaher)
  • 6.18. Becton, Dickinson and Company
  • 6.19. Biocartis
  • 6.20. Biomatik
  • 6.21. bioMerieux Diagnostics
  • 6.22. Bioneer Corporation
  • 6.23. Bio-Rad Laboratories, Inc.
  • 6.24. Bio-Synthesis
  • 6.25. Bio-Techne
  • 6.26. Boditech Med, Inc
  • 6.27. Boster Biological Technology
  • 6.28. Bruker
  • 6.29. Cerstest Biotec
  • 6.30. Chembio
  • 6.31. CTK Biotech
  • 6.32. Cue Health
  • 6.33. Cytena
  • 6.34. Diasorin S.p.A.
  • 6.35. Dynex Technologies
  • 6.36. Eiken Chemical
  • 6.37. Enzo Biochem
  • 6.38. Eurofins Scientific
  • 6.39. Fluxion Biosciences (Cell Microsystems)
  • 6.40. FUJIFILM Wako Diagnostics
  • 6.41. Fujirebio
  • 6.42. Global Access Diagnostics
  • 6.43. Gold Standard Diagnostics
  • 6.44. Greiner Bio-One
  • 6.45. Grifols
  • 6.46. Hycor Biomedical
  • 6.47. Immunodiagnostic Systems (IDS)
  • 6.48. Iollo
  • 6.49. JR Biomedical
  • 6.50. LightDeck Diagnostics
  • 6.51. LumiraDx
  • 6.52. Maxim Biomedical
  • 6.53. Meso Scale Discovery
  • 6.54. Millipore Sigma
  • 6.55. Mindray
  • 6.56. Molecular Devices
  • 6.57. MP Biomedical
  • 6.58. Operon
  • 6.59. OraSure Technologies
  • 6.60. Qiagen
  • 6.61. QuidelOrtho
  • 6.62. R&D Systems
  • 6.63. Randox Toxicology
  • 6.64. R-Biopharm AG
  • 6.65. Response Biomedical
  • 6.66. Revvity
  • 6.67. Roche Diagnostics
  • 6.68. SD Biosensor
  • 6.69. Siemens Healthineers
  • 6.70. Standard BioTools
  • 6.71. Sysmex
  • 6.72. Tecan
  • 6.73. Thermo Fisher Scientific
  • 6.74. TOSOH Bioscience
  • 6.75. Uniogen
  • 6.76. Veramarx
  • 6.77. Veredus Laboratories
  • 6.78. Vircell
  • 6.79. Wantai Biopharm
  • 6.80. Werfen
  • 6.81. YD Diagnostics
  • 6.82. Zhejiang Orient Gene Biotech

7. The Global Market

  • 7.1. Global Market by Country
    • 7.1.1. Global Market by Country Table
    • 7.1.2. Global Market by Country Chart
  • 7.2. Global Market by Application
    • 7.2.1. Global Market by Application Table
    • 7.2.2. Global Market by Application Segment Growth Chart
    • 7.2.3. Global Market by Application Segment Annual Chart
    • 7.2.4. Global Market by Application Segment Base vs. Final
    • 7.2.5. Global Market by Application Base Year
    • 7.2.6. Global Market by Application Final Year
  • 7.3. Global Market by Technology
    • 7.3.1. Global Market by Technology Table
    • 7.3.2. Global Market by Technology Segment Growth Chart
    • 7.3.3. Global Market by Technology Segment Annual Chart
    • 7.3.4. Global Market by Technology Segment Base vs. Final
    • 7.3.5. Global Market by Technology Base Year
    • 7.3.6. Global Market by Technology Final Year
  • 7.4. Global Market by Product
    • 7.4.1. Global Market by Product Table
    • 7.4.2. Global Market by Product Segment Growth Chart
    • 7.4.3. Global Market by Product Segment Annual Chart
    • 7.4.4. Global Market by Product Segment Base vs. Final
    • 7.4.5. Global Market by Product Base Year
    • 7.4.6. Global Market by Product Final Year
  • 7.5. Global Market by User
    • 7.5.1. Global Market by User Table
    • 7.5.2. Global Market by User Segment Growth Chart
    • 7.5.3. Global Market by User Segment Annual Chart
    • 7.5.4. Global Market by User Segment Base vs. Final
    • 7.5.5. Global Market by User Base Year
    • 7.5.6. Global Market by Application Final Year

8. Global Market by Application

  • 8.1. Endocrinology Applications
    • 8.1.1. Endocrinology Applications by Country Table
    • 8.1.2. Endocrinology Applications Growth Chart
  • 8.2. Immune Applications
    • 8.2.1. Immune Applications by Country Table
    • 8.2.2. Immune Applications Growth Chart
  • 8.3. Oncology Applications
    • 8.3.1. Oncology Applications by Country Table
    • 8.3.2. Oncology Applications Growth Chart
  • 8.4. Infectious Disease Applications
    • 8.4.1. Infectious Disease Applications by Country Table
    • 8.4.2. Infectious Disease Applications Growth Chart
  • 8.5. Cardiology Applications
    • 8.5.1. Cardiology Applications by Country Table
    • 8.5.2. Cardiology Applications Growth Chart
  • 8.6. Other Applications
    • 8.6.1. Other Applications by Country Table
    • 8.6.2. Other Applications Growth Chart

9. Immunoassay by Technology

  • 9.1. Enzyme
    • 9.1.1. Enzyme by Country Table
    • 9.1.2. Enzyme Growth Chart
  • 9.2. Flourescence
    • 9.2.1. Flourescence by Country Table
    • 9.2.2. Flourescence Growth Chart
  • 9.3. Chemiluminescence
    • 9.3.1. Chemiluminescence by Country Table
    • 9.3.2. Chemiluminescence Growth Chart
  • 9.4. Nucleic Acid
    • 9.4.1. Nucleic Acid by Country Table
    • 9.4.2. Nucleic Acid Growth Chart
  • 9.5. Rapid/POC
    • 9.5.1. Rapid/POC by Country Table
    • 9.5.2. Rapid/POC Growth Chart
  • 9.6. Other Technology
    • 9.6.1. Other Technology by Country Table
    • 9.6.2. Other Technology Growth Chart

10. Immunoassay by Product

  • 10.1. Instrument
    • 10.1.1. Instrument by Country Table
    • 10.1.2. Instrument Growth Chart
  • 10.2. Reagents
    • 10.2.1. Reagents by Country Table
    • 10.2.2. Reagents Growth Chart
  • 10.3. Services
    • 10.3.1. Services by Country Table
    • 10.3.2. Services Growth Chart

11. Immunoassay by User

  • 11.1. Hospital
    • 11.1.1. Hospital by Country Table
    • 11.1.2. Hospital Growth Chart
  • 11.2. Outpatient Lab
    • 11.2.1. Outpatient Lab by Country Table
    • 11.2.2. Outpatient Lab Growth Chart
  • 11.3. POC/Other
    • 11.3.1. POC/Other by Country Table
    • 11.3.2. POC/Other Growth Chart

12. Vision of the Future of Immunoassay

13. Appendices

  • 13.1. Growth of Approved IVD Test Menu
  • 13.2. Growth of Approved Average IVD Test Fee
  • 13.3. The Most Used IVD Assays
  • 13.4. The Highest Grossing Assays
  • 13.5. Laboratory Fees Schedule

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus-Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: The Different Markets for Immunoassay
  • Table 6: The Factors Driving Growth
  • Table 7: Factors Limiting Growth
  • Table 8: The Global Immunoassay Market by Country
  • Table 9: Global Market by Application
  • Table 10: Global Market by Technology
  • Table 11: Global Market by Product
  • Table 12: Global Market by User
  • Table 13: Endocrinology Immunoassay by Country
  • Table 14: Immune Immunoassay by Country
  • Table 15: Oncology Immunoassay by Country
  • Table 16: Infectious Disease Immunoassay by Country
  • Table 17: Cardiology Immunoassay by Country
  • Table 18: Other Immunoassay by Country
  • Table 19: Enzyme Immunoassay by Country
  • Table 20: Flourescence Immunoassay by Country
  • Table 21: Chemiluminescence Immunoassay by Country
  • Table 22: Nucleic Acid Immunoassay by Country
  • Table 23: Rapid/POC Immunoassay by Country
  • Table 24: Other Technology Immunoassay by Country
  • Table 25: Instrument by Country
  • Table 26: Reagents by Country
  • Table 27: Services by Country
  • Table 28: Hospital Usrr by Country
  • Table 29: Outpatient Lab by Country
  • Table 30: POC/Other by Country
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays
  • Table 33: Clinical Lab Fee Schedule

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Lab Test Pie
  • Figure 3: The Road to Diagnostics
  • Figure 4: Immunoassay-Country Sharea
  • Figure 5: Chart of Growth by Application
  • Figure 6: Chart of Segment by Year
  • Figure 7: Chart of Base vs. Final
  • Figure 8: Chart of Base Year by Application
  • Figure 9: Chart of Final Year by Application
  • Figure 10: Chart of Growth by Technology
  • Figure 11: Chart of Technology Segment by Year
  • Figure 12: Chart of Technology Base vs. Final
  • Figure 13: Chart of Base Year by Technology
  • Figure 14: Chart of Final Year by Technology
  • Figure 15: Chart of Growth by Product
  • Figure 16: Chart of Product Segment by Year
  • Figure 17: Chart of Product Base vs. Final
  • Figure 18: Chart of Base Year by Product
  • Figure 19: Chart of Final Year by Product
  • Figure 20: Chart of Growth by User
  • Figure 21: Chart of User Segment by Year
  • Figure 22: Chart of User Base vs. Final
  • Figure 23: Chart of Base Year by User
  • Figure 24: Chart of Final Year by User
  • Figure 25: Chart-Endocrine Segment vs Total Market Growth
  • Figure 26: Chart-Immune Growth vs. Total
  • Figure 27: Chart-Oncology vs Total
  • Figure 28: Chart-Infectious Disease Immunoassay vs Total
  • Figure 29: Chart-Cardiology Immunoassay vs total
  • Figure 30: Chart-Other Immunoassay vs Total
  • Figure 31: Chart-Enzyme Segment vs Total Market Growth
  • Figure 32: Chart-Flourescence Growth vs. Total
  • Figure 33: Chart-Chemiluminescence vs Total
  • Figure 34: Chart-Nucleic Acid Immunoassay vs Total
  • Figure 35: Chart-Rapid/POC Immunoassay vs total
  • Figure 36: Chart-Other Technology Immunoassay vs Total
  • Figure 37: Chart-Instrument Segment vs Total Market Growth
  • Figure 38: Chart-Reagents Growth vs. Total
  • Figure 39: Chart-Services vs Total
  • Figure 40: Chart-Hospital Segment vs Total Market Growth
  • Figure 41: Chart-Outpatient Lab Growth vs. Total
  • Figure 42: Chart-POC/Other vs Total
  • Figure 43: IVD Test Menu Growth
  • Figure 44: IVD Test Average Fees-A Ten Year View